Lyn activity is elevated in GBM, the highest grade of glioma tumors, as well as in breast cancer, acute myelocytic leukemia (AML), B-cell chronic lymphocytic leukemia (CLL) and Ewing’s sarcoma [13]–[19]. Here, LYN is linked to acute myeloid leukemia.